- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba's MR Interface Receives FDA Clearance
Toshiba American Systems Inc. today announced FDA clearance of their M-Power interface aimed at increasing MR exam efficiency. The customizable user interface enables technologists to streamline and accelerate the imaging process and enhance diagnosis, according to the company.
Toshiba American Systems Inc. today announced FDA clearance of their M-Power interface aimed at increasing MR exam efficiency. The customizable user interface enables technologists to streamline and accelerate the imaging process and enhance diagnosis, according to the company.
M-Power will be available for use on Toshiba’s Vantage Atlas, Vantage Titan 1.5 and Titan 3T MR systems with the ability to upgrade already-installed systems.
M-Power reduces the steps to start a procedure, and the interface is designed to enhance and personalize work flow. The Atlas Compass software automates coil selection and turns on the proper coil elements needed for an exam. Finally, mVOX, a volume imaging acquisition sequence available for neuro and orthopedic applications, allows the acquisition of all 3D imaging to be acquired at the same time, according to the company.
“M-Power makes Toshiba’s sophisticated suite of MR software easy to learn and use, allowing technologists of every skill level to access the system’s full range of functionality,” Stuart Clarkson, director, MR Business Unit, Toshiba, said in the company release. “MR technologists are now able to design their own protocols and easily access mTools for greater convenience and productivity.”
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
